Rheumatoid arthritis (RA) is treated with medications that slow or stop the immune system from attacking your joints, combined with lifestyle strategies that protect joint function and reduce pain. With modern treatment, roughly 30 to 50% of patients achieve clinical remission, and many more reach a state of low disease activity where symptoms are well controlled. The key is starting treatment early and adjusting it aggressively until inflammation is under control.
Why Early, Aggressive Treatment Matters
RA causes damage because the immune system produces inflammatory signals that drive the cells lining your joints to multiply and invade surrounding cartilage and bone. Left unchecked, this process is progressive and irreversible. The goal of modern treatment is not just pain relief but remission: stopping the inflammatory process before it destroys joint structure. Doctors call this “treat to target,” meaning they monitor inflammation markers and adjust medications until a specific level of disease control is reached.
The first few months after diagnosis are sometimes called the “window of opportunity.” Joint damage accumulates fastest in the first two years, so the sooner treatment begins, the better the long-term outcome.
Starting With Methotrexate
Methotrexate is the first medication prescribed for nearly all newly diagnosed RA patients. It works by dialing down the overactive immune response that drives joint inflammation. A typical starting dose is 15 mg taken once a week, then increased by 5 mg each month until symptoms improve or the dose reaches 25 to 30 mg per week. It takes time to work. Most people don’t feel the full benefit for 8 to 12 weeks, and finding the right dose can take several months of gradual increases.
Because methotrexate can affect your liver, blood cell counts, and kidneys, you’ll need regular blood tests. In the first three months, expect blood work every two to four weeks. After that, the schedule stretches to every 8 to 12 weeks, and eventually every 12 weeks once you’re on a stable dose. These tests are routine and help catch any problems long before they cause symptoms. Taking a folic acid supplement alongside methotrexate reduces side effects like nausea and mouth sores.
Bridging With Steroids
Since methotrexate takes weeks to kick in, doctors often prescribe a short course of a corticosteroid like prednisolone to control pain and swelling in the meantime. A common approach is starting at 15 to 20 mg daily, then reducing the dose by 5 mg each week until you’re off it. This “bridging” strategy gives you relief while the longer-term medication builds up in your system. If your RA is especially severe at diagnosis, the starting dose may be higher or the taper slower.
When Methotrexate Isn’t Enough
If methotrexate alone doesn’t bring your RA under adequate control after three to six months, the next step is usually adding a biologic medication. The most commonly used biologics target a protein called TNF-alpha, one of the main drivers of joint inflammation. TNF-alpha triggers the cells in your joint lining to produce enzymes that break down cartilage and bone. Blocking it can dramatically reduce swelling, slow joint damage, and in many cases push the disease into remission.
Five TNF-blocking biologics are available, and they’re typically given as self-administered injections or intravenous infusions at varying intervals, from twice a week to once a month. Most people continue taking methotrexate alongside a biologic because the combination works better than either drug alone. Other biologics target different parts of the immune system. If one biologic doesn’t work well, switching to a different one with a different mechanism often does.
Oral Alternatives to Biologics
A newer class of medications called JAK inhibitors offers an oral pill option for people with moderate to severe RA. Three are currently approved for RA: tofacitinib, baricitinib, and upadacitinib. They work by blocking specific signaling pathways inside immune cells, reducing the cascade of inflammation at its source.
These medications carry a boxed warning from the FDA about increased risks of serious cardiovascular events, blood clots, and certain cancers. Because of these risks, JAK inhibitors are generally reserved for patients who haven’t responded adequately to one or more biologic treatments, or who can’t tolerate injections. Your rheumatologist will weigh the benefits against your individual risk factors, including age, smoking status, and heart health history.
Protecting Your Joints Day to Day
Medication is the foundation of RA treatment, but how you use your joints throughout the day has a real impact on pain and long-term function. Occupational therapists specialize in teaching people with RA how to perform daily tasks with less joint strain. Key strategies include joint protection techniques (like using your palms instead of your fingers to push open doors), energy conservation (pacing activities and resting before you’re exhausted), and using assistive devices that reduce the force on small joints.
Splints are another practical tool. Resting splints worn at night keep inflamed joints in a neutral position and can reduce morning stiffness. Working splints support your wrists or fingers during tasks without completely immobilizing them. These aren’t signs of giving in to the disease. They’re tools that reduce pain and help preserve joint alignment over years.
Regular physical activity, particularly low-impact exercise like swimming, cycling, or walking, strengthens the muscles around your joints and improves overall function. Strength training is safe and beneficial for most people with RA as long as you avoid exercising a joint that’s actively hot and swollen.
Diet and Inflammation
No diet replaces RA medication, but certain dietary patterns appear to lower inflammation as an add-on to standard treatment. A randomized trial called ADIRA tested a diet rich in omega-3 fatty acids, fiber, and probiotics in RA patients and found a significant reduction in disease activity scores during the intervention period. Omega-3 fatty acids, found in fatty fish, walnuts, and flaxseed, have the most consistent evidence. Multiple studies show they can reduce tender joint counts and lower markers of inflammation in the blood.
A Mediterranean-style eating pattern, heavy on vegetables, fruit, whole grains, olive oil, and fish while low in red meat and processed foods, aligns well with these findings. It’s not a dramatic dietary overhaul for most people, and the general health benefits extend well beyond RA.
Ongoing Monitoring and Adjusting Treatment
RA treatment is not a set-it-and-forget-it situation. You’ll see your rheumatologist regularly, typically every three to six months once your disease is stable, to assess how well your current medications are working. These visits usually include blood tests to check inflammation levels and monitor for medication side effects, along with a physical examination of your joints.
The specific blood work depends on which medications you’re taking. For methotrexate and similar drugs, liver enzymes, blood cell counts, and kidney function are checked at every visit. For biologic medications, the schedule is similar: blood tests four to eight weeks after starting and every three months after that. Kidney function is checked at least once a year regardless of your treatment, since kidney problems are more common in people with RA.
If your disease flares, your treatment plan gets adjusted. That might mean a temporary course of steroids, a dose increase, or a switch to a different medication. The goal stays the same throughout: get to remission or the lowest possible disease activity, and stay there. With the range of treatments now available, most people with RA can find a combination that controls their disease and lets them live without significant limitations.